Health Newsfeed – Johns Hopkins Medicine Podcasts

People undergoing immunotherapy treatment for cancer and who got a Covid vaccine survived longer than those who did not get the vaccine, a new study finds. Jeff Coller, an mRNA expert at Johns Hopkins, examines why this hasn’t been seen …

Why haven’t we seen cancer fighting effects with vaccines other than the Covid vaccines? Elizabeth Tracey reports Read more →

If you were being treated for lung cancer or melanoma with immunotherapy and you received a Covid vaccine, you got a surprising benefit: you were twice as likely to survive your cancer as those who did not get a vaccine, …

mRNA could comprise a generic vaccine to be used for cancer, Elizabeth Tracey reports Read more →

People with lung cancer or melanoma who were receiving immunotherapy and got a Covid vaccine within 100 days of initiating treatment saw dramatically improved survival compared to those folks who did not receive a vaccine, a new study shows. mRNA …

The benefit of mRNA vaccines in cancer treatment is ongoing, Elizabeth Tracey reports Read more →

Combating cancer may soon include immunization with an mRNA vaccine, as studies accumulate demonstrating their benefit in revving up the immune system against the disease. mRNA expert Jeff Coller at Johns Hopkins says this is one way to engage your …

mRNA vaccines take advantage of the body’s own systems, Elizabeth Tracey reports Read more →

Receipt of an mRNA vaccine for Covid within 100 days of beginning immunotherapy for lung cancer or melanoma increased a person’s survival likelihood by a factor of two or greater, a new study shows. Johns Hopkins mRNA expert Jeff Coller …

Might mRNA vaccines replace chemotherapy for cancer treatment? Elizabeth Tracey reports Read more →

mRNA vaccines saved millions of lives during the Covid-19 pandemic. Now a new study points to their effectiveness in helping people survive cancer. The study looked at people who received a Covid vaccine within 100 days of starting immunotherapy for …

Can mRNA vaccines treat cancer? Elizabeth Tracey reports Read more →

Testing a fluid known as cerebrospinal fluid, or CSF, found surrounding the brain and spinal cord, reveals a lot about brain tumors and the immune response to them. Johns Hopkins neurosurgery department director Chetan Bettegowda and test developer says this …

Can a new test of cerebrospinal fluid be used for many diseases of the brain and spinal cord? Elizabeth Tracey reports Read more →

Tumor components and immune response indicators can be found in cerebrospinal fluid, or CSF, when someone has a brain tumor, in a new test developed by Chetan Bettagowda, director of neurosurgery at Johns Hopkins and one of the test’s developers.  …

Cerebrospinal fluid may hold the keys to brain cancer identification and treatment, Elizabeth Tracey reports Read more →

Your immune system has everything to do with how your body responds to cancer, and brain tumors are no exception. A new test aims to assess that along with characterizing the tumor itself. Chetan Bettegowda, director of neurosurgery at Johns …

What does your immune response have to do with brain tumors? Elizabeth Tracey reports Read more →

Your brain and spinal cord are floating in something called cerebrospinal fluid, or CSF, and when brain tumors develop they shed cells and cellular components into this fluid. A new test developed by director of neurosurgery Chetan Bettegowda at Johns …

Cerebrospinal fluid can tell lots about brain tumors, Elizabeth Tracey reports Read more →